Alnylam Pharmace. sell fchar99
Start price
26.09.17
/
50%
€100.57
Target price
26.03.18
€73.96
Performance (%)
24.00%
End price
26.03.18
€124.70
Summary
This prediction ended on 26.03.18 with a price of €124.70. The SELL prediction by fchar99 finished with a performance of 24.00%. fchar99 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 6.750% | 6.750% | 4.542% | 61.035% |
| iShares Core DAX® | -0,22 % | 1,75 % | 2,66 % | 57,51 % |
| iShares Nasdaq 100 | -2,35 % | 0,22 % | 32,49 % | 88,48 % |
| iShares Nikkei 225® | -3,10 % | 2,93 % | 56,98 % | 75,66 % |
| iShares S&P 500 | -0,50 % | 1,99 % | 24,47 % | 68,57 % |
Comments by fchar99 for this prediction
In the thread Alnylam Pharmace. diskutieren
Schau auf negative Zahlen!
Blick auf Beschreibung und Finanzen! LOTS von - #S (NEGATIVE) -----! Ich bin großzügig mit mu Preis!
(Laufzeit überschritten)